Factors Influencing Drug Uptake during Mass Drug Administration for Control of Lymphatic Filariasis in Rural and Urban Tanzania
Open Access
- 8 October 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (10) , e109316
Abstract
In most countries of Sub-Saharan Africa, control of lymphatic filariasis (LF) is based on annual mass drug administration (MDA) with a combination of ivermectin and albendazole. Treatment coverages are however often suboptimal for programmes to reach the goal of transmission interruption within reasonable time. The present study aimed to identify predictors and barriers to individual drug uptake during MDA implementation by the National LF Elimination Programme in Tanzania. A questionnaire based cross sectional household survey was carried out in two rural and two urban districts in Lindi and Morogoro regions shortly after the 2011 MDA. 3279 adults (≥15 years) were interviewed about personal characteristics, socio-economic status, MDA drug uptake among themselves and their children, reasons for taking/not taking drugs, and participation in previous MDA activities for LF control. The overall drug uptake rate was 55.1% (range of 44.5–75.6% between districts). There was no overall major difference between children (54.8%) and adults (55.2%) or between females (54.9%) and males (55.8%), but the role of these and other predictors varied to some extent between study sites. Major overall predictors of drug uptake among the interviewed adults were increasing age and history of previous drug uptake. Being absent from home during drug distribution was the main reason for not taking the drugs (50.2%) followed by clinical contraindications to treatment (10.8%), missing household visits of drug distributors (10.6%), and households not being informed about the distribution (9.0%). Drug uptake relied more on easily modifiable provider-related factors than on individual perceptions and practices in the target population. Limited investments in appropriate timing, dissemination of accurate timing information to recipients and motivation of drug distributors to visit all households (repeatedly when residents are absent) are likely to have considerable potential for increasing drug uptake, in support of successful LF transmission elimination.Keywords
This publication has 25 references indexed in Scilit:
- A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic FilariasisPLOS Neglected Tropical Diseases, 2013
- Lymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmissionBMC Infectious Diseases, 2013
- Urban lymphatic filariasisParasitology Research, 2012
- The Role of Personal Opinions and Experiences in Compliance with Mass Drug Administration for Lymphatic Filariasis Elimination in KenyaPLOS ONE, 2012
- WILL MASS DRUG ADMINISTRATION ELIMINATE LYMPHATIC FILARIASIS? EVIDENCE FROM NORTHERN COASTAL TANZANIAJournal of Biosocial Science, 2012
- Predictors of compliance with a mass drug administration programme for lymphatic filariasis in Orissa State, India 2008Tropical Medicine & International Health, 2010
- Neglected Tropical Diseases in Sub-Saharan Africa: Review of Their Prevalence, Distribution, and Disease BurdenPLOS Neglected Tropical Diseases, 2009
- Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, PhilippinesParasites & Vectors, 2008
- Factors influencing drug compliance in the mass drug administration programme against filariasis in the Western province of Sri LankaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2007
- Participation in three consecutive mass drug administrations in Leogane, HaitiTropical Medicine & International Health, 2006